Ellen K. Donnelly, Ph.D - Chief Executive Officer

Chief Executive Officer

Ellen K. Donnelly, Ph.D., joined Modus Therapeutics in 2017 from Pfizer, where she held various leadership positions in Clinical Operations, Project and Portfolio Management and Research. Most recently Dr. Donnelly was responsible for Clinical Operations for Pfizer’s Neuroscience and Pain therapeutic area. Dr. Donnelly also brings biotech and management consulting experience to the CEO role. Dr. Donnelly received her Ph.D. from Yale University.